Workflow
P/B ratio
icon
Search documents
AB or CG: Which Is the Better Value Stock Right Now?
ZACKS· 2025-03-27 16:40
Core Viewpoint - The comparison between AllianceBernstein (AB) and Carlyle Group (CG) indicates that AB presents a better value opportunity for investors at this time due to stronger earnings estimate revisions and more attractive valuation metrics [1][3][7]. Valuation Metrics - AllianceBernstein has a forward P/E ratio of 10.69, while Carlyle Group has a forward P/E of 10.81 [5]. - The PEG ratio for AB is 0.84, indicating a more favorable expected earnings growth rate compared to CG's PEG ratio of 1.07 [5]. - AB's P/B ratio stands at 2.09, compared to CG's P/B ratio of 2.60, suggesting that AB is more undervalued relative to its book value [6]. Analyst Outlook - AB holds a Zacks Rank of 2 (Buy), reflecting a more positive analyst outlook due to stronger earnings estimate revision activity, while CG has a Zacks Rank of 3 (Hold) [3][7]. - The Value grade for AB is B, indicating it is considered undervalued, whereas CG has a Value grade of C [6].
BCS vs. EBKDY: Which Stock Is the Better Value Option?
ZACKS· 2025-03-25 16:40
Core Viewpoint - The article compares Barclays (BCS) and Erste Group Bank AG (EBKDY) to determine which stock is more attractive to value investors [1] Group 1: Zacks Rank and Earnings Outlook - Barclays has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook compared to Erste Group Bank AG, which has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank emphasizes stocks with strong earnings estimate revision trends, which is a key factor for value investors [2] Group 2: Valuation Metrics - Barclays has a forward P/E ratio of 7.90, while Erste Group Bank AG has a forward P/E of 9.11, suggesting that Barclays may be undervalued [5] - The PEG ratio for Barclays is 0.41, indicating a favorable valuation relative to its expected earnings growth, whereas Erste Group Bank AG has a PEG ratio of 1.15 [5] - Barclays has a P/B ratio of 0.62, compared to Erste Group Bank AG's P/B of 0.94, further supporting the argument that Barclays is the superior value option [6] Group 3: Value Grades - Based on various valuation metrics, Barclays holds a Value grade of B, while Erste Group Bank AG has a Value grade of D, reinforcing the conclusion that Barclays is the more attractive investment [6]
MEG or CWST: Which Is the Better Value Stock Right Now?
ZACKS· 2025-03-24 16:45
Core Insights - Montrose Environmental (MEG) is currently rated as a 2 (Buy) by Zacks Rank, while Casella (CWST) holds a 3 (Hold) rating, indicating a more favorable outlook for MEG [3] - MEG has shown positive revisions in earnings estimates, suggesting an improving earnings outlook compared to CWST [3] Valuation Metrics - MEG has a forward P/E ratio of 13.06, significantly lower than CWST's forward P/E of 95.09, indicating that MEG may be undervalued [5] - The PEG ratio for MEG is 0.36, while CWST's PEG ratio is 3.69, further suggesting that MEG is more attractive in terms of growth relative to its price [5] - MEG's P/B ratio stands at 1.12, compared to CWST's P/B of 4.51, reinforcing the notion that MEG is a better value investment [6] - Overall, MEG has a Value grade of A, while CWST has a Value grade of C, highlighting MEG's superior valuation metrics [6]
SCHW vs. MKTX: Which Stock Is the Better Value Option?
ZACKS· 2025-03-20 16:40
Core Insights - The article compares The Charles Schwab Corporation (SCHW) and MarketAxess (MKTX) to identify which stock presents a better value opportunity for investors [1] Valuation Metrics - SCHW has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while MKTX has a Zacks Rank of 3 (Hold) [3] - SCHW's forward P/E ratio is 18.66, significantly lower than MKTX's forward P/E of 28.15 [5] - SCHW has a PEG ratio of 0.97, while MKTX's PEG ratio is much higher at 4.99, suggesting SCHW is more reasonably priced relative to its expected earnings growth [5] - SCHW's P/B ratio stands at 3.58, compared to MKTX's P/B of 5.89, further indicating that SCHW is undervalued [6] - Based on these metrics, SCHW holds a Value grade of B, whereas MKTX has a Value grade of F, highlighting SCHW's superior valuation [6] Conclusion - Given the stronger estimate revision activity and more attractive valuation metrics, SCHW is positioned as the superior option for value investors at this time [7]
BDORY vs. SMFG: Which Stock Is the Better Value Option?
ZACKS· 2025-03-18 16:40
Core Insights - The article compares Banco Do Brasil SA (BDORY) and Sumitomo Mitsui (SMFG) to determine which stock offers better value for investors [1] Valuation Metrics - BDORY has a forward P/E ratio of 4.14, significantly lower than SMFG's forward P/E of 41.13 [5] - BDORY's PEG ratio is 1.47, while SMFG's PEG ratio is 2.42, indicating that BDORY may offer better value relative to its expected earnings growth [5] - BDORY's P/B ratio is 0.80, compared to SMFG's P/B of 1.04, suggesting that BDORY is undervalued in terms of market value versus book value [6] Zacks Rank and Value Grades - BDORY has a Zacks Rank of 1 (Strong Buy), while SMFG has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook for BDORY [3] - Based on various valuation metrics, BDORY holds a Value grade of B, whereas SMFG has a Value grade of D, further supporting the conclusion that BDORY is the more attractive option for value investors [6]
NNGRY vs. BWIN: Which Stock Is the Better Value Option?
ZACKS· 2025-03-18 16:40
Core Viewpoint - Investors in the Life Insurance sector should consider NN Group NV Unsponsored ADR (NNGRY) and The Baldwin Insurance Group (BWIN) for potential value opportunities [1] Valuation Metrics - NNGRY has a forward P/E ratio of 7.19, while BWIN has a forward P/E of 22.21 [5] - NNGRY's PEG ratio is 0.72, indicating a more favorable valuation compared to BWIN's PEG ratio of 1.04 [5] - NNGRY's P/B ratio is 0.66, significantly lower than BWIN's P/B of 4.73, suggesting NNGRY is undervalued relative to its book value [6] Analyst Outlook - NNGRY has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings estimate revision trend, while BWIN has a Zacks Rank of 3 (Hold) [3] - The stronger estimate revision activity for NNGRY suggests a more favorable analyst outlook compared to BWIN [7] Value Grades - NNGRY has a Value grade of B, while BWIN has a Value grade of D, reflecting NNGRY's more attractive valuation metrics [6]
PYPL or MA: Which Is the Better Value Stock Right Now?
ZACKS· 2025-03-14 16:41
Investors interested in stocks from the Financial Transaction Services sector have probably already heard of Paypal (PYPL) and MasterCard (MA) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes co ...
BKEAY vs. NABZY: Which Stock Should Value Investors Buy Now?
ZACKS· 2025-03-13 17:09
Core Viewpoint - The Bank of East Asia Ltd. (BKEAY) is currently viewed as a more attractive investment option compared to National Australia Bank Ltd. (NABZY) for value investors seeking undervalued stocks [1][3][7] Valuation Metrics - BKEAY has a forward P/E ratio of 6.25, significantly lower than NABZY's forward P/E of 14.37 [5] - The PEG ratio for BKEAY is 0.80, indicating a favorable valuation in relation to its expected earnings growth, while NABZY's PEG ratio is much higher at 7.64 [5] - BKEAY's P/B ratio stands at 0.25, which is substantially lower than NABZY's P/B ratio of 1.57, suggesting that BKEAY is undervalued relative to its book value [6] Zacks Rank and Style Scores - BKEAY holds a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions, while NABZY has a Zacks Rank of 4 (Sell) [3] - BKEAY has earned a Value grade of A, contrasting with NABZY's Value grade of F, highlighting BKEAY's stronger position in terms of value metrics [6]
GILD vs. VRTX: Which Stock Is the Better Value Option?
ZACKS· 2025-03-13 17:09
Core Insights - Investors in the Medical - Biomedical and Genetics sector should consider Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) for potential value opportunities [1] Valuation Metrics - GILD has a forward P/E ratio of 14.49, while VRTX has a forward P/E of 28.07, indicating GILD may be undervalued compared to VRTX [5] - GILD's PEG ratio is 0.74, suggesting a favorable valuation when considering expected earnings growth, whereas VRTX's PEG ratio is 1.20 [5] - GILD's P/B ratio is 7.38, compared to VRTX's P/B of 7.78, further supporting GILD's stronger valuation metrics [6] Analyst Outlook - GILD currently holds a Zacks Rank of 2 (Buy), indicating a more favorable earnings estimate revision activity compared to VRTX, which has a Zacks Rank of 3 (Hold) [3][6] - The solid earnings outlook for GILD positions it as the superior value option in comparison to VRTX [6]
ABM vs. CTAS: Which Stock Is the Better Value Option?
ZACKS· 2025-03-06 17:45
Core Viewpoint - Investors in the Business - Services sector should consider ABM Industries and Cintas as potential undervalued stocks, with ABM currently appearing to be the superior value option based on various valuation metrics [1][6]. Valuation Metrics - Both ABM Industries and Cintas have a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and an improving earnings outlook for both companies [3]. - ABM has a forward P/E ratio of 14.13, significantly lower than Cintas's forward P/E of 47.58, suggesting that ABM may be undervalued relative to Cintas [5]. - The PEG ratio for ABM is 2.73, while Cintas has a PEG ratio of 3.96, further indicating that ABM is more favorably valued when considering expected earnings growth [5]. - ABM's P/B ratio stands at 1.85, compared to Cintas's P/B of 19.28, reinforcing the notion that ABM is a better value option [6]. - Based on these valuation figures, ABM earns a Value grade of A, while Cintas receives a Value grade of D, highlighting the relative undervaluation of ABM [6].